Effects of HIIT in Tolerance to Exercise of Individuals With HF and Coexisting COPD
NCT ID: NCT04350541
Last Updated: 2021-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
40 participants
INTERVENTIONAL
2019-09-01
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High-intensity Interval Training in Patients With COPD: a Fidelity and Tolerability Study
NCT05273684
Acute Effects of Supramaximal High-Intensity Interval Training in People With COPD
NCT05874999
Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease
NCT06068322
High Intensity Interval Training and Technologies in COPD
NCT05343949
Cardiopulmonary Adaptations to High-intensity Interval Training (HIIT) in COPD
NCT06551441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interval training
Interval training will consist of 10 minutes of warm-up between 40-50% of the peak oxygen consumption (VO2peak), followed by four to six repetitions of three-minute intervals between 80-90% of VO2peak and three minutes between 40-50% VO2peak and finally, five minutes of cooling down between 30-40% of VO2peak.
High-intensity interval training
Exercise with high-intensity intervals followed by active rest
Continuous training
The continuous aerobic training will consist of 10 minutes of warm-up with intensity between 40 and 50% of VO2peak, 20 minutes of conditioning between 60 and 70% of VO2peak and 5 minutes of cooling down between 30 and 40% of VO2peak.
Continuous aerobic training
Interval Moderate-intensity aerobic training without intervals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-intensity interval training
Exercise with high-intensity intervals followed by active rest
Continuous aerobic training
Interval Moderate-intensity aerobic training without intervals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed moderate and severe chronic obstructive pulmonary disease;
* Clinical stability;
* No change in the medication class within three months before the beginning of the research.
Exclusion Criteria
* Myocardial infarction;
* Previous cardiac surgery up to three months before the beginning of the study;
* Hemodynamic instability;
* Orthopedic and neurological diseases;
* Psychological and/or mental impairment.
50 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Pernambuco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
BRUNA THAYS SANTANA DE ARAĆJO
physiotherapist, clinical research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal University of Pernambuco
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07640919.4.0000.5208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.